These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28692311)

  • 1. Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
    Okamura K; Shirai K; Totake N; Okuda T; Urata H
    Clin Exp Hypertens; 2018; 40(2):99-106. PubMed ID: 28692311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension.
    Tani S; Asayama K; Oiwa K; Harasawa S; Okubo K; Takahashi A; Tanabe A; Ohkubo T; Hirayama A; Kushiro T
    Hypertens Res; 2017 Oct; 40(10):892-898. PubMed ID: 28446804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
    Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
    Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study.
    Ishimitsu T; Fukuda H; Uchida M; Ishibashi K; Sato F; Nukui K; Nagao M
    Clin Exp Hypertens; 2015; 37(7):542-50. PubMed ID: 25978131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study).
    Motozato K; Miura S; Shiga Y; Kusumoto T; Adachi S; Inoue T; Fujisawa K; Saku K
    Clin Exp Hypertens; 2016; 38(1):45-50. PubMed ID: 26268636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of suitable antihypertensive therapies: Combination with high-dose amlodipine/irbesartan vs triple combination with amlodipine/irbesartan/indapamide (ASAHI-AI study).
    Nakagawa N; Sato N; Saijo Y; Morimoto H; Koyama S; Ogawa Y; Uekita K; Maruyama J; Ohta T; Nakamura Y; Takeuchi T; Hasebe N;
    J Clin Hypertens (Greenwich); 2020 Sep; 22(9):1577-1584. PubMed ID: 32762115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G; Schmieder R; Calvo C; Asmar R
    Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
    Tóth K;
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):137-45. PubMed ID: 24590580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR.
    Páll D; Szántó I; Szabó Z
    Clin Drug Investig; 2014 Oct; 34(10):701-8. PubMed ID: 25212574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study.
    Zhang Y; Agnoletti D; Safar ME; Blacher J
    Hypertension; 2011 Aug; 58(2):155-60. PubMed ID: 21747047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy.
    Garnock-Jones KP
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):141-50. PubMed ID: 23516133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1).
    Zemmrich C; Lüders S; Gansz A; Sturm CD; Fimmers R; Nadal J; Schmieder RE; Schrader J; Bramlage P
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):815-9. PubMed ID: 24102831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure control with a single-pill combination of indapamide sustained-release and amlodipine in patients with hypertension: the EFFICIENT study.
    Jadhav U; Hiremath J; Namjoshi DJ; Gujral VK; Tripathi KK; Siraj M; Shamanna P; Safar M
    PLoS One; 2014; 9(4):e92955. PubMed ID: 24714044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.